Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1 to 15 of 729 results for innovative

  1. Innovative treatment of leakage and anastomotic insufficiency

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  2. Our role in the Innovative Licensing and Access Pathway (ILAP)

    The Innovative Licensing and Access Pathway (ILAP) is a unique initiative which works with medicine developers early on to help get new medicines to patients faster.

  3. Niraparib with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer (terminated appraisal) (TA1032)

    NICE is unable to make a recommendation about the use in the NHS of niraparib (Zejula) with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer in adults. This is because Johnson & Johnson Innovative Medicine did not provide an evidence submission.

    Technology appraisal guidance
    Published
    22 January 2025

    Sections for TA1032

  4. NICE encourages further research into the use of innovative technologies for the management of severe acute respiratory failure, and may review this guidance on publication of further evidence.

    IPG391/1 Question NICE encourages further research into the use of innovative technologies for the management of severe acute...

    Research recommendation
    Published
    9 June 2015

  5. Tools for building or evaluating an evidence base

    Tools for building or evaluating a medtech evidence base with NICE

  6. New hope for people with breathing condition, COPD, as NICE approves innovative treatment

    Breakthrough therapy reduces flare-ups by almost a third and could ease pressure on NHS hospitals.

    News
    Last updated
    26 January 2026

  7. Health Technology Assessment Innovation Laboratory (HTA Lab)

    NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.

  8. Methods research areas

    NICE priority methodological research areas.

  9. Office for Digital Health

    The Office for Digital Health strives to accelerate NICE's efforts to deliver innovation to the health and care system.

  10. Life sciences: how to get your product to market

    NICE Advice works closely with our system partners and industry to drive innovation into the hands of health and care professionals, to enable best practice.

  11. Register your organisation as a stakeholder

    Our stakeholders are involved in the development of NICE guidance and quality standards to ensure that the recommendations are relevant, practical, and meet the needs of those affected by the health or social care issues addressed.

  12. Register your organisation as a stakeholder

    Our stakeholders are involved in the development of NICE guidance and quality standards to ensure that the recommendations are relevant, practical, and meet the needs of those affected by the health or social care issues addressed.

  13. One-piece closed bags for colostomies: late-stage assessment (HTG754)

    Late stage assessment (LSA) guidance on one-piece closed bags for colostomies

    HealthTech guidance
    Published
    10 July 2025
    View recommendations

    Sections for HTG754

  14. Early access to medicines scheme (EAMS)

    A joint NICE and NHS England meeting can help to ensure you're ready for NHS patient access and subsequent NICE appraisal

  15. Our research work

    Our science policy and research programme team produces high-quality, impactful research.